Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

被引:208
作者
Masteller, EL
Warner, MR
Tang, QZ
Tarbell, KV
McDevitt, H
Bluestone, JA
机构
[1] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94395 USA
关键词
D O I
10.4049/jimmunol.175.5.3053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD(4+)CD25(+)Foxp(3+) regulatory T cells (T-reg) are critical for controlling autoinummity. Evidence suggests that T-reg development, peripheral maintenance, and suppressive function are dependent on Ag specificity. However, there is little direct evidence that the T-reg responsible for controlling autoimmunity in NOD mice or other natural settings are Ag specific. In fact, some investigators have argued that polyclonal Ag-nonspecific T-reg are efficient regulators of immunity. Thus, the goal of this study was to identify, expand, and characterize islet Ag-specific T-reg in NOD mice. Ag-specific Treg from NOD mice were efficiently expanded in vitro using IL-2 and beads coated with recombinant islet peptide mimic-MHC class II and anti-CD28 mAb. The expanded Ag-specific T-reg expressed prototypic surface markers and cytokines. Although activated in an Ag-specific fashion, the expanded T-reg were capable of bystander suppression both in vitro and in vivo. Importantly, the islet peptide mimic-specific T-reg were more efficient than polyclonal Treg in suppressing autoimmune diabetes. These results provide a direct demonstration of the presence of autoantigen-specific T-reg in the natural setting that can be applied as therapeutics for organ-specific autoimmunity.
引用
收藏
页码:3053 / 3059
页数:7
相关论文
共 17 条
[1]   T cell regulation as a side effect of homeostasis and competition [J].
Barthlott, T ;
Kassiotis, G ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :451-460
[2]   Therapeutic vaccination using CD4+ CD25+ antigen-specific regulatory T cells [J].
Bluestone, JA ;
Tang, QZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 :14622-14626
[3]   Autoreactive T cells in healthy individuals [J].
Danke, NA ;
Koelle, DM ;
Yee, C ;
Beheray, S ;
Kwok, WW .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :5967-5972
[4]   Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development [J].
Gregori, S ;
Giarratana, N ;
Smiroldo, S ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2003, 171 (08) :4040-4047
[5]   Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors [J].
Hsieh, CS ;
Liang, YQ ;
Tyznik, AJ ;
Self, SG ;
Liggitt, D ;
Rudensky, AY .
IMMUNITY, 2004, 21 (02) :267-277
[6]   Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice [J].
Judkowski, V ;
Pinilla, C ;
Schroder, K ;
Tucker, L ;
Sarvetnick, N ;
Wilson, DB .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :908-917
[7]   FOLLOWING A DIABETOGENIC T-CELL FROM GENESIS THROUGH PATHOGENESIS [J].
KATZ, JD ;
WANG, B ;
HASKINS, K ;
BENOIST, C ;
MATHIS, D .
CELL, 1993, 74 (06) :1089-1100
[8]   CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes [J].
Lenschow, DJ ;
Herold, KC ;
Rhee, L ;
Patel, B ;
Koons, A ;
Qin, HY ;
Fuchs, E ;
Singh, B ;
Thompson, CB ;
Bluestone, JA .
IMMUNITY, 1996, 5 (03) :285-293
[9]   Detection of low-avidity CD4+ T cells using recombinant artificial APC:: Following the antiovalbumin immune response [J].
Mallet-Designe, VI ;
Stratmann, T ;
Homann, D ;
Carbone, F ;
Oldstone, MBA ;
Teyton, L .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :123-131
[10]   Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes [J].
Masteller, EL ;
Warner, MR ;
Ferlin, W ;
Judkowski, V ;
Wilson, D ;
Glaichenhaus, N ;
Bluestone, JA .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :5587-5595